Natural Product for the Interventions of Chronic Diseases: From Source to Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 3331
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue, titled "Natural Product for the Interventions of Chronic Diseases: From Source to Therapy", invites innovative research works that bridge the gap between the natural world and therapeutic applications for chronic conditions. Chronic diseases, such as rheumatoid arthritis, diabetes, and various forms of cancer, represent a growing burden on global health. Natural products have historically provided a rich source of pharmacological agents, and their role in chronic disease intervention remains an area ripe for exploration. This issue will focus on the discovery, analysis, and application of natural compounds in the prevention and treatment of chronic diseases. Submissions should highlight advancements in the selective extraction and refinement of bioactive components, the evaluation of their therapeutic potential, and the exploration of the molecular mechanisms through which these compounds exert their effects. We welcome studies that employ state-of-the-art techniques for the identification and enhancement of the therapeutic properties of natural products, as well as research that offers insight into the pharmacodynamics and pharmacokinetics of these potential treatments. By integrating traditional understanding with modern scientific approaches, this Special Issue aims to further the development of natural products as efficacious agents in the long-term management of chronic diseases. This Special Issue only includes research “with defined molecular compound”.
Dr. Qilei Chen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- chronic diseases
- drug discovery
- pharmacodynamics
- pharmacokinetics
- nanotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
